Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02243748 · ClinicalTrials.gov registry record · NA

Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers

A NA study, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
361
Enrollment target

NCT02243748 is a NA study that has completed, run by City of Hope Medical Center. The registered enrollment target is 361 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02243748, a NA study, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
361 participants
Enrollment target

Study Summary

This clinical trial studies a palliative care intervention in improving symptom control and quality of life in patients with stage II-IV non-small cell lung cancer and their family caregivers. Palliative care programs can provide patients and their caregivers with information on how to manage their symptoms, maintain health and well-being, and access supportive care services. An interdisciplinary palliative care model may effectively link lung cancer patients to the appropriate supportive care services in a timely fashion.

Interventions

  • OTHER questionnaire administration
  • OTHER quality-of-life assessment
  • OTHER Palliative Therapy

Trial Details

FieldValue
Enrollment Target 361 participants
Start Date 2015-02
Est. Completion 2019-04-22
Phase NA

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT02243748

The ClinicalTrials.gov registry entry for NCT02243748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 361 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.

NCT02243748 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02243748 about?

NCT02243748 is a clinical study titled "Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers". This clinical trial studies a palliative care intervention in improving symptom control and quality of life in patients with stage II-IV non-small cell lung cancer and their family caregivers. Palliative care programs can provide patients and their caregivers with information on how to manage their ...

What is the current status of trial NCT02243748?

This trial is currently completed. It is a NA study. The enrollment target is 361 participants. The study started on 2015-02. Estimated completion is 2019-04-22.

What interventions are being tested in trial NCT02243748?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (OTHER), Palliative Therapy (OTHER).

Who is sponsoring clinical trial NCT02243748?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.